Veteran investment professional focused on growth equity and operational value creation across technology and healthcare, with experience sourcing deals, leading follow-on rounds and partnering with founders to scale revenue and margins. Debbie Fox combines operating leadership and investor diligence, with a background in corporate strategy, portfolio operations and fund-level governance.
Veteran investment professional focused on growth equity and operational value creation across technology and healthcare, with experience sourcing deals, leading follow-on rounds and partnering with founders to scale revenue and margins. Debbie Fox combines operating leadership and investor diligence, with a background in corporate strategy, portfolio operations and fund-level governance.
Focuses on growth equity investments in technology and healthcare, prioritizing scalable business models where operational improvements can unlock margin expansion and revenue acceleration. Emphasizes founder alignment, disciplined follow-on capital allocation, and rigorous diligence that blends corporate-strategy thinking with hands-on portfolio operations. Seeks companies with clear go-to-market leverage, durable unit economics, and pathways to market leadership where active governance and KPI-driven operational interventions drive value. Time horizon is growth-stage multi-year scaling rather than short-term exits; risk management centers on staging capital, milestone-based value creation plans, and close operator-investor collaboration.
Focuses on growth equity investments in technology and healthcare, prioritizing scalable business models where operational improvements can unlock margin expansion and revenue acceleration. Emphasizes founder alignment, disciplined follow-on capital allocation, and rigorous diligence that blends corporate-strategy thinking with hands-on portfolio operations. Seeks companies with clear go-to-market leverage, durable unit economics, and pathways to market leadership where active governance and KPI-driven operational interventions drive value. Time horizon is growth-stage multi-year scaling rather than short-term exits; risk management centers on staging capital, milestone-based value creation plans, and close operator-investor collaboration.
| Trades 814 | Longs Won 541/814 66% | Profit Factor 5.66 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $417,748.33 |
| Average Win $132,839.62 | Best Trade (Jul 16) $6.13M | Sharpe Ratio -9.67 |
| Average Loss -$46,519.92 | Worst Trade (Jul 15) -$1.56M | Z-Score 5.48 (100%) |
| Commissions $0 | Avg. Trade Length 10m 2w 2d | Expectancy $72,685.87 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 6,329 | 5,696 | 5,063 | 4,430 | 3,797 | 3,165 | 2,532 | 1,899 | 1,266 | 633 |